Inventor · disambiguated record
David Charles Rees
Also filed as: REES DAVID · REES DAVID C · REES DAVID CHARLES
27 granted patents·11 pending applications·471 citations·filing 1989–2024
97Inventor score
Top patents by PatentIndex Score
38 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0295US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0395US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0495US9458158B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 4, 2016·11 cites·22 claims
- 0595US4906655ANovel 1,2-cyclohexylaminoaryl amides useful as analgesic agentsWARNER LAMBERT CO·Filed 1989·Granted Mar 6, 1990·98 cites·16 claims
- 0694US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0792US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0892US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0991US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 1090US9155743B2Bicyclic heterocycle compounds and their uses in therapyBUCK ILDIKO MARIA·Filed 2012·Granted Oct 13, 2015·12 cites·18 claims
- 1190US5051428A2-amino-4 or 5-methoxycyclohexyl amides useful as analgesicsWARNER LAMBERT CO·Filed 1990·Granted Sep 24, 1991·47 cites·6 claims
- 1288US5019588A1-oxaspiro[4,5] decane-7,8-diaminoarylamidesWARNER LAMBERT CO·Filed 1989·Granted May 28, 1991·43 cites·13 claims
- 1385US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 1484US8013163B24-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Sep 6, 2011·7 cites·22 claims
- 1584US5594022ATachykinin antagonistsWARNER LAMBERT CO·Filed 1994·Granted Jan 14, 1997·38 cites·51 claims
- 1682US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1779US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 1877US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1976US8497294B2Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinasesWOODHEAD STEVEN JOHN·Filed 2011·Granted Jul 30, 2013·7 cites·8 claims
- 2076US7265099B1Use of chemical chelators as reversal agents for drug-induced neuromuscular blockORGANON NV·Filed 2000·Granted Sep 4, 2007·16 cites·3 claims
- 2176US4965278A7-(substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agentsWARNER LAMBERT CO·Filed 1989·Granted Oct 23, 1990·22 cites·3 claims
- 2270US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 2370US5593967ACholecystokinin antagonists, their preparation and therapeutic useWARNER LAMBERT CO·Filed 1993·Granted Jan 14, 1997·22 cites·8 claims
- 2468US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2567US8293767B24-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitorsWYATT PAUL GRAHAM·Filed 2011·Granted Oct 23, 2012·2 cites·16 claims
- 2667US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2766US5716979ATachykinin antagonistsWARNER LAMBERT CO·Filed 1996·Granted Feb 10, 1998·17 cites·33 claims
- 2858US2010075938A1Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular BlockORGANON NV·Filed 2009·Application pending·0 cites
- 2956US5981755ATachykinin antagonistsWARNER LAMBERT CO·Filed 1998·Granted Nov 9, 1999·8 cites·2 claims
- 3054US2010113551A1Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinasesASTEX THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 3151US2007299035A1Use of chemical chelators as reversal agents for drug-induced neuromuscular blockORGANON NV·Filed 2007·Application pending·0 cites
- 3245US5856354ATachykinin antagonistsWARNER LAMBERT CO·Filed 1997·Granted Jan 5, 1999·4 cites·31 claims
- 3345US2009318500A14-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of CancerASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3443US5063242A7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agentsWARNER LAMBERT CO·Filed 1990·Granted Nov 5, 1991·10 cites·3 claims
- 3542US5922681AEndothelin antagonistsWARNER LAMBERT CO·Filed 1992·Granted Jul 13, 1999·8 cites·16 claims
- 3641US2007208015A15-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase ModulatorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3739US2014288040A1Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infectionASTEX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 3838US2004048830A1Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disordersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Charles Rees files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →